Effectiveness of phosphate binders on mortality and cardiovascular disease in end-stage renal disease patients with hyperphosphatemia: a multicenter real-world cohort study
Sign Up to like & getrecommendations! Published in 2025 at "BMC Nephrology"
DOI: 10.1186/s12882-025-04058-7
Abstract: Uncontrolled hyperphosphatemia in end stage renal disease (ESRD) increases the risk of cardiovascular disease (CVD), bone disorders, and premature mortality. Randomized controlled trials show reduced CVD risk of non-calcium-based phosphate-binders (NCBPBs) compared to CBPBs although… read more here.
Keywords: cbpbs; disease; free time; cardiovascular disease ... See more keywords